Our Network
Omico is a nationwide network of research and treatment centres that facilitate, support and promote genomic cancer medicine. Central to this is the use of molecular screening for the prevention and treatment of cancer.
New South Wales
Garvan Institute of Medical Research (MoST, RiSC and SMOC+ screening) (ASPiRATION – **open** for screening)
NHMRC Clinical Trials Centre (University of Sydney)
The Kinghorn Cancer Centre (St Vincent’s Hospital, Darlinghurst) (MoST, RiSC and SMOC+)
Chris O’brien Lifehouse (Camperdown) (MoST and RiSC) (ASPiRATION date to be advised – 2021)
St George Hospital (Kogarah) (MoST)
Royal North Shore Hospital (North Sydney) (ASPiRATION – **open** for screening)
Westmead Hospital (Westmead) (ASPiRATION – **open** for screening)
Prince of Wales Hospital (Randwick) (MoST) (opening soon)
Border Medical Oncology (ASPiRATION date to be advised 2021)
Victoria
Peter MacCallum Cancer Centre (MoST, RiSC and SMOC+) (ASPiRATION – **open** for screening)
Monash Partners Comprehensive Cancer Consortium (MoST screening)
Austin Health (MoST opening soon) (ASPiRATION date to be advised 2021)
St Vincent’s Hospital, Fitzroy (ASPiRATION – **open** for screening)
Tasmania
Royal Hobart Hospital (MoST) (ASPiRATION – **open** for screening)
Australian Capital Territory
Canberra Hospital (MoST) (ASPiRATION date to be advised 2021)
Queensland
Princess Alexandra Hospital (MoST) (ASPiRATION – **open** for screening)
Royal Brisbane and Women’s Hospital (MoST-LLy)
Prince Charles Hospital (ASPiRATION – **open** for screening)
South Australia
Royal Adelaide Hospital (MoST and SMOC+) (MoST-LLy – opening soon) (ASPiRATION – **open** for screening)
Northern Territory
Royal Darwin Hospital (MoST) (ASPiRATION date to be advised 2021)
Western Australia
Linear Clinical Research Limited (MoST) (ASPiRATION – **open** for screening)
New Zealand
Auckland Hospital (opening soon)
Our Members
